Search

Displaying results 6561 - 6570 of 10000 in total
  1. Drug

    DAS-431 IV

    go.drugbank.com/drugs/DB05432
    Experimental

    DAS-431 IV is a dopamine D1 receptor agonist developed by DrugAbuse Sciences for the treatment of Addictions, Schizophrenia, Schizoaffective Disorders, Dementia, Parkinson's Disease, Strokes etc.

  2. Drug

    Cianopramine

    go.drugbank.com/drugs/DB19470
    Experimental

    Cianopramine is a small molecule drug. The usage of the INN stem '-pramine' in the name indicates that Cianopramine is a substance of the imipramine group. … Cianopramine has a monoisotopic molecular weight of 305.19 Da.

    Categories: Heterocyclic Compounds, 3-Ring
  3. Drug

    Azipramine

    go.drugbank.com/drugs/DB19636
    Experimental

    Azipramine is a small molecule drug. The usage of the INN stem '-pramine' in the name indicates that Azipramine is a substance of the imipramine group. … Azipramine has a monoisotopic molecular weight of 366.21 Da.

  4. Drug

    Depramine

    go.drugbank.com/drugs/DB20198
    Experimental

    Depramine is a small molecule drug. The usage of the INN stem '-pramine' in the name indicates that Depramine is a substance of the imipramine group. … Depramine has a monoisotopic molecular weight of 278.18 Da.

    Categories: Heterocyclic Compounds, 3-RingSynonyms: Imipramine hydrochloride impurity b
  5. Drug

    Ketipramine

    go.drugbank.com/drugs/DB21245
    Experimental

    Ketipramine is a small molecule drug. The usage of the INN stem '-pramine' in the name indicates that Ketipramine is a substance of the imipramine group. … Ketipramine has a monoisotopic molecular weight of 294.17 Da.

    Categories: Heterocyclic Compounds, 3-Ring
  6. Drug

    Aldosterone

    go.drugbank.com/drugs/DB04630
    Investigational

    A hormone secreted by the adrenal cortex that regulates electrolyte and water balance by increasing the renal retention of sodium and the excretion of potassium.

    Categories: P-glycoprotein inducers, P-glycoprotein substratesSynonyms: (11β)-11,21-dihydroxy-3,20-dioxopregn-4-en-18-al, 11beta,21-Dihydroxy-3,20-dioxo-4-pregnen-18-al
  7. Drug

    N-Formylmethionine

    go.drugbank.com/drugs/DB04464
    Experimental

    N-Formylmethionine is effective in the initiation of protein synthesis. The initiating methionine residue enters the ribosome as N-formylmethionyl tRNA. … This process occurs in Escherichia coli and other bacteria as well as in the mitochondria of eucaryotic cells.

    Synonyms: (2S)-2-(formylamino)-4-(methylthio)butanoic acid, L-N-Formylmethionine
  8. Drug

    Bisegliptin

    go.drugbank.com/drugs/DB06127
    Investigational

    Bisegliptin is a compound for the treatment of type 2 diabetes. … It is an orally active, dipeptidyl peptidase-IV (DPPIV) inhibitor which lowers blood glucose levels by blocking the degradation of the hormone GLP-1 thereby stimulating glucose-dependent insulin secretion

  9. Drug

    Tonapofylline

    go.drugbank.com/drugs/DB12569
    Investigational

    Tonapofylline has been used in trials studying the treatment of Heart Failure, Renal Insufficiency, and Congestive Heart Failure.

    Categories: Heterocyclic Compounds, 2-Ring
  10. Drug

    CX157

    go.drugbank.com/drugs/DB05205
    Investigational

    CX157,3-fluoro-7-(2,2,2,-trifluoroethoxy)phenoxathiin-10,10-dioxide, is a reversible, selective inhibitor of MAO-A designed to have improved oral bioavailability and reduced clearance compared to previous … MAO-A inhibitors of this class.